Nalaganje...
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib
Dasatinib is a small-molecule kinase inhibitor used for the treatment of imatinib-resistant chronic myelogenous leukemia (CML). We have analyzed the kinases targeted by dasatinib by using an unbiased chemical proteomics approach to detect binding proteins directly from lysates of CML cells. Besides...
Shranjeno v:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
National Academy of Sciences
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1940229/ https://ncbi.nlm.nih.gov/pubmed/17684099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0702654104 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|